Alaunos Therapeutics, Inc. - Common Stock TCRT 深 滬
等待開盤 07-18 09:30:00 美东时间
3.26
+0.010
+0.31%
華盛通- 最 高3.9399
- 今 開3.23
- 成交量 5.02万股
- 最 低 3.23
- 昨 收 3.25
- 總市值 534.48万
- 52周最高 6.20
- 市盈率 靜 --
- 換手率 3.06%
- 52周最低 1.3137
- 委 比 -34.55%
- 總股本 163.95万
- 歷史最高 2239.50
- 量 比 0.47
- 振 幅 21.84%
- 歷史最低 1.3137
- 每 手 1
- 風險率 0.92%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Alaunos Therapeutics Raises $850,000 in Private Offering
An announcement from Alaunos Therapeutics ( ($TCRT) ) is now available. On June...
06-26 21:18
Alaunos Therapeutics stock slides on $2M equity offering
Alaunos Therapeutics (NASDAQ:TCRT) shares fell over 14% premarket on Monday after the company launched an equity offering to raise around $2M in proceeds. The offering comprises 610,399 shares of comm...
06-23 20:45
Alaunos Therapeutics Announces $2.0 Million Registered Direct Offering
Alaunos Therapeutics has completed a registered direct offering of approximately 610,399 shares at $3.36 per share, raising around $2.0 million to support its obesity program and general corporate initiatives. The offering, conducted under a 2022 SEC-registered shelf, is set to close on June 24, 2025, subject to customary conditions.
06-23 12:00
PMGC Capital Urges Alaunos Therapeutics To Accept Financing Term Sheet Previously Facilitated By Leading Wall Street Bank
PMGC Capital LLC ("PMGC Capital"), a wholly owned subsidiary of PMGC Holdings Inc. (NASDAQ:ELAB), today issued a public statement urging Alaunos Therapeutics, Inc. (NASDAQ:TCRT) to accept and act upon the term sheet
06-18 21:54
PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) to Accept Term Sheet from Leading Wall Street Bank Behind Many Leading Crypto Strategies
PMGC Capital LLC, a subsidiary of PMGC Holdings Inc., has urged Alaunos Therapeutics, Inc. to accept a term sheet facilitated by a leading Wall Street bank. PMGC Capital holds a significant ownership position in Alaunos and believes the proposed financing represents a compelling opportunity to maximize shareholder value. The term sheet, described as non-toxic and well-structured, provides substantial capital and potential value creation. PMGC Cap...
06-18 13:52
Alaunos Therapeutics Amends Warrant Agreement with Mast Hill
Alaunos Therapeutics ( ($TCRT) ) has issued an announcement. On May 19, 2025, A...
06-10 18:40
Alaunos Therapeutics Board Opts for Equity Compensation
Alaunos Therapeutics ( ($TCRT) ) just unveiled an update. On April 13, 2025, Al...
04-16 05:30
Alaunos Therapeutics Ends Licensing Deal, Reassesses Strategy
The latest announcement is out from Alaunos Therapeutics ( ($TCRT) ). Alaunos T...
2024-10-10 20:57
重磅：晚期实体瘤治疗新突破，香雪TCR-T细胞治疗新药纳入突破性治疗品种
2024年7月30日，中国国家药品监督管理局 (NMPA) 药品审评中心（CDE）同意香雪生命科学（XLifeSc）的TAEST16001注射液纳入突破性治疗品...
2024-07-31 10:31
